Saturday 17 October 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 18.9%, EPS grew 81.3%, free cash flow grew 19.1% and total debt fell 25.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

16.51 0.22 −1.32%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.9×
Fwd P/E: 16.5×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	20.65%	59.91%	64.98%	66.12%
Piotroski F-Score Full definition →		9	8	7	7
ROA Full definition →		14.46%	44.11%	48.54%	48.52%
ROIC Full definition →		71.84%	30.35%	34.24%	40.76%
Return on Tangible Assets Full definition →		21.34%	71.74%	75.37%	70.86%
Average Days of Receivables Full definition →		42.19	53.46	60.17	48.20
Free Cash Flow per Share Full definition →		0.91	1.01	1.26	1.35
Free Cash Flow Full definition →		119.87	135.41	166.64	175.07
Capital Expenditures Full definition →		(0.24)	(0.25)	(0.27)	(0.18)
Other line items
Cash ROIC Full definition →		15.50%	13.13%	16.76%	15.89%
Accounts Receivable Turnover Full definition →		7.91	7.26	6.66	7.67
Accounts Payable Turnover Full definition →		1.00	7.69	8.89	11.90
Inventory Turnover Full definition →		0.70	0.77	0.66	0.66
Average Days of Payables Full definition →		27.47	37.02	31.74	21.08
Days of Inventory on Hand Full definition →		555.76	510.54	553.66	548.68
Tax Rate Full definition →		(0.02)	1.52	1.23	0.96
Research and Development Expense of Revenue Full definition →		11.18%	11.48%	11.48%	12.79%
Selling, General and Administrative Expense of Revenue Full definition →		41.22%	35.96%	34.69%	32.41%
Share Based Compensation of Revenue Full definition →		6.36%	5.19%	5.77%	4.69%
Interest Coverage Full definition →		18.09	26.43	30.38	34.25
Operating CF/Net income Full definition →		1.54	0.47	0.56	0.56
Depreciation/Fixed assets Full definition →		8.58	9.21	9.77	10.41
Capex/Depreciation Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Revenue per Share Full definition →		2.02	2.11	2.25	2.39
Operating CF per Share Full definition →		0.91	1.01	1.26	1.35
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly